up to now number of years, the united kingdom has witnessed a revolution in medical bodyweight‑decline treatment options — in the introduction of semaglutide (Wegovy®) on the escalating reputation of tirzepatide (Mounjaro®). Now, An additional name is drawing attention in the two clinical and gen